The designation of the Swiss Authorised Representative (CH REP) is required to market all Medical Devices, including legacy devices, i.e. devices covered by a certificate still valid in compliance with the MDD / AIMDD Directives and class I devices that will require the intervention of a Notified Body (ON) which can continue to be made available on the market or put into service until May 27, 2025.

Discover the strategic-regulatory consultancy services Thema


Do you want to stay updated on the main news regarding the Switzerland – EU Agreement in the field of Medical Devices?

Fill out the form and receive periodically our THEMA: SWISS NEWS by email!

Error: Contact form not found.